A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combined with Chemotherapy Versus Imatinib Combined with Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Project: Research

Project Details

StatusActive
Effective start/end date19/07/24 → 5/12/26

Keywords

  • clinical trial
  • leukaemia
  • chemotherapy
  • Imatinib